Gastrointestinal Cancer News

Rates of past-year screening for breast, cervical and prostate cancer in 2021 remained below prepandemic levels as millions of eligible Americans continued to forgo testing, according to a study published in Journal of Clinical Oncology.

The economic cost of cancer worldwide from 2020 to 2050 will be $25.2 trillion in international dollars, according to results of a decision analytical modeling study published in JAMA Oncology.

Healio | HemOnc Today is excited to announce a new physician leadership structure, which features seven Associate Medical Editors from various subspecialty areas within oncology and hematology.

SAN FRANCISCO — The newly reignited Cancer Moonshot is centered on the goal to reduce cancer deaths by 50% over the next 25 years.

The addition of pembrolizumab to chemotherapy significantly extended survival among patients with advanced HER2-negative gastric or gastroesophageal junction cancer, according to results of the phase 3 KEYNOTE-859 study.

The incidence of pancreatic cancer increased at a faster rate over time among women aged younger than 55 years compared with their male counterparts, according to research published in Gastroenterology.

In this video interview, Cecilia Monge, MD, MPH, FACP, from the NCI Center for Cancer Research at NIH, discussed the SUNLIGHT trial data presented at ASCO Gastrointestinal Cancers Symposium.

In a video interview with Healio, Cecilia Monge, MD, MPH, FACP, from the NCI Center for Cancer Research at NIH, talked about the NAPOLI 3 trial data presented at ASCO Gastrointestinal Cancers Symposium.

Cecilia Monge, MD, MPH, FACP, from the NCI Center for Cancer Research at NIH, discussed her ASCO Gastrointestinal Cancers Symposium presentation on racial and ethnic disparities in liver and biliary tract cancer clinical trials.

Referrals from low-volume to high-volume centers appeared associated with longer OS among patients with pancreatic ductal adenocarcinoma, according to study results published in JAMA Surgery.